In 2020, researchers within our adult and childhood arthritis programmes will be featured in every issue of Arthritis Digest , opening with Professor Wendy Thomson, our Programme Lead forInflammatory Arthritis in Children.
The first global patient has taken part in a clinical trial testing the effectiveness and safety of a new treatment for a rare inflammatory muscle disease. Professor Hector Chinoy is the UK chief investigator of the study and Dr James Lilleker is a sub-investigator. Both are BRC researchers within
Our researchers are contributing to the largest ever project of its kind, which aims to increase understanding of patient responses to the treatment of seven long-term diseases.
A ‘life-changing’ potential new drug could be available to lupus patients in the future thanks to ‘breakthrough’ research. The results of the TULIP II study have been published in the New England Journal of Medicine (NEJM), one of the most prestigious, peer-reviewed medical journals in the world.
A Manchester woman with a rare syndrome has spoken about the impact it has had on her life, and how the care she has received at Manchester Royal Infirmary has vastly improved how she manages her condition.
Researchers at the NIHR Manchester Biomedical Research Centre (BRC) have recently been awarded academic promotions by The University of Manchester.
Dr Hector Chinoy, a Manchester BRC researcher, has received funding and materials support from pharmaceutical company, Lilly, to conduct an innovative research study in the rare disease, Myositis.
In this blog, Dr Rebecca Lee considers what she learnt from her visit to one of the USA’s top five paediatric research centres and the applications for her own research.